| Literature DB >> 26787547 |
Jia Guo1, Stefanie Thiess1, Inger Johansson1, Souren Mkrtchian1, Magnus Ingelman-Sundberg1.
Abstract
Cytochrome P450 2W1 (CYP2W1) is a colon tumor-specific enzyme, suggested as a potential target for cancer therapy. In contrast to other endoplasmic reticulum P450s, we found completely inverted ER membrane topology of CYP2W1 using different approaches (redox sensitive luciferase assay and protease protection assay) and demonstrated that canonical CYP reductants, cytochrome P450 reductase, and cytochrome b5 cannot serve as electron donors for CYP2W1. Moreover, the reduced catalytic activity of the Asn177 mutant that is modified by glycan moieties in the wild-type enzyme indicates a functional relevance of CYP2W1 glycosylation.Entities:
Keywords: P450 reductase; cytochrome P450 2W1; cytochrome b5; electron donor; glycosylation; membrane topology
Mesh:
Substances:
Year: 2016 PMID: 26787547 DOI: 10.1002/1873-3468.12063
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124